Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (2.87%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2023)
Net Profit:
0 Million
Pharmaceuticals & Biotechnology
USD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.33
-999,999.00%
-0.00






